Heart failure & cardiomyopathies
Heart failure: assessment of the global economic burden
Authors' conclusion
The global economic burden of HF is substantial, increasing, and varies across countries. Although very high and high HDI countries carry most of the absolute costs, low HDI countries bear a disproportionate burden relative to their total healthcare expenditure or GDP.
Study context
- Population
- Studies reporting direct and/or indirect costs of heart failure (HF); 179 countries, categorised by Human Development Index32 studies
- Outcome
- Global economic burden of HF (direct and indirect costs)
- Follow-up
- 2021
Methodological detailsPRISMA
- PRISMA
Pooled result
As reported in the abstract
Global economic burden of HF
Total estimated economic burden, 179 countries
$284.17 billion
Direct cost
$136.86 billion
48.16%
Indirect cost
$147.31 (51.84%) billion
Further pooled results
HF costs as share of current healthcare expenditure and gross domestic product (GDP), by Human Development Index (HDI) · 2021
- Very high HDI countries (most absolute spending)
- 1.07% direct cost (DC), 0.09% indirect cost (IC)
- Low HDI countries
- 8.85% DC, 0.29% IC
Original publication
Heart failure: assessment of the global economic burden. Eur Heart J. Published 30 May 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →